Exhale

The official blog of the Lung Institute.

Is Emphysema a Fatal Disease?

23 Aug 2017
| Under Disease Education, Emphysema, Lung Disease | Posted by | 14 Comments
Is Emphysema a Fatal Disease?

There is no cure for emphysema. However, describing it as “fatal” may not be entirely accurate. While emphysema does shorten life expectancy, many patients are able to manage their symptoms with treatment and live long, fulfilling lives.

The long-term effects of emphysema and other forms of chronic obstructive pulmonary disease (COPD) largely depend on the extent of the disease at diagnosis. For example, according to the National Institutes of Health, an individual who is diagnosed with stage 1 or 2 COPD may have a life expectancy that is, at most, a few years shorter than someone without lung disease. On the other hand, someone who is diagnosed with stage 3 or 4 COPD may lose approximately six years of life expectancy.

It is important to note that each case is unique and should be treated as such. There are several factors that can positively or negatively influence an emphysema patient’s prognosis, including:

  • The age at diagnosis
  • The specific type of emphysema
  • The patient’s overall health
  • Lifestyle factors such as weight, diet and smoking habits

Because there is not yet a cure for emphysema, traditional treatment methods like supplemental oxygen therapy and inhaled corticosteroids focus on helping patients breathe more easily and maintain a positive quality of life. While this approach is often effective for patients with early-stage emphysema, symptoms can become more severe and harder to manage as the disease progresses.

The Lung Institute offers an alternative form of care to emphysema patients who don’t find satisfactory relief from their symptoms with traditional treatments alone. As the world’s first cellular therapy center to focus exclusively on pulmonary disease, the Lung Institute is a leader in cellular therapy. This innovative treatment leverages the body’s natural ability to heal itself and uses the patient’s own cells to help preserve lung function, reduce inflammation and slow disease progression.

If you are ready to explore your alternative treatment options for emphysema, we encourage you to contact the Lung Institute at (800) 729-3065 to speak with a member of our devoted medical team.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.